Chimerix (CMRX) News Today $0.88 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 3, 2024 | markets.businessinsider.comChimerix to Present at H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Shares Cross Below 200 Day Moving Average of $0.97Chimerix (NASDAQ:CMRX) Share Price Crosses Below Two Hundred Day Moving Average of $0.97September 1, 2024 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Sees Significant Drop in Short InterestChimerix, Inc. (NASDAQ:CMRX - Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 1,690,000 shares, a drop of 10.6% from the July 31st total of 1,890,000 shares. Approximately 2.1% of the shares of the company are short sold. Based on an average daily volume of 485,300 shares, the days-to-cover ratio is currently 3.5 days.August 30, 2024 | globenewswire.comChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 28, 2024 | americanbankingnews.comChimerix (NASDAQ:CMRX) Upgraded to "Hold" at StockNews.comAugust 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP)August 21, 2024 | uk.finance.yahoo.comChimerix Inc (CXF.DU)August 16, 2024 | marketbeat.comShort Interest in Chimerix, Inc. (NASDAQ:CMRX) Expands By 18.1%Chimerix, Inc. (NASDAQ:CMRX - Get Free Report) was the target of a significant increase in short interest in July. As of July 31st, there was short interest totalling 1,890,000 shares, an increase of 18.1% from the July 15th total of 1,600,000 shares. Based on an average daily volume of 213,100 shares, the days-to-cover ratio is presently 8.9 days. Currently, 2.4% of the company's stock are short sold.August 16, 2024 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Expected to Post Q1 2025 Earnings of ($0.24) Per ShareChimerix, Inc. (NASDAQ:CMRX - Free Report) - Stock analysts at Wedbush dropped their Q1 2025 earnings estimates for Chimerix in a note issued to investors on Tuesday, August 13th. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company will post earnings of ($0.24) per sharAugust 15, 2024 | marketbeat.comEquities Analysts Offer Predictions for Chimerix, Inc.'s FY2028 Earnings (NASDAQ:CMRX)Chimerix, Inc. (NASDAQ:CMRX - Free Report) - Equities researchers at Capital One Financial reduced their FY2028 EPS estimates for shares of Chimerix in a research note issued on Tuesday, August 13th. Capital One Financial analyst N. Quibria now forecasts that the biopharmaceutical company will eaAugust 14, 2024 | finance.yahoo.comQ2 2024 Chimerix Inc Earnings CallAugust 14, 2024 | nz.finance.yahoo.comChimerix, Inc. (CXF.F)August 14, 2024 | msn.comWHO declares mpox in Africa is a global health emergencyAugust 14, 2024 | msn.comChimerix, Inc. (NASDAQ:CMRX) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Chimerix (NASDAQ:CMRX)HC Wainwright restated a "buy" rating and set a $11.00 target price on shares of Chimerix in a report on Wednesday.August 14, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Announces Quarterly Earnings ResultsChimerix (NASDAQ:CMRX - Get Free Report) posted its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.23) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.23). Chimerix had a negative net margin of 25,337.96% and a negative return on equity of 41.32%. The business had revenue of $0.13 million for the quarter, compared to analyst estimates of $1.26 million. During the same quarter last year, the business posted ($0.21) EPS.August 13, 2024 | marketbeat.comChimerix's (CMRX) Outperform Rating Reaffirmed at WedbushWedbush restated an "outperform" rating and set a $6.00 target price on shares of Chimerix in a research report on Tuesday.August 13, 2024 | msn.comSwiss Funding Bodies ‘Talk Money’ and Co-Financing Opportunities at Locarno: ‘We Create a Space Where Stories Take Shape’August 13, 2024 | markets.businessinsider.comChimerix earnings preview: what Wall Street is expectingAugust 13, 2024 | finance.yahoo.comChimerix Reports Second Quarter 2024 Financial Results and Provides Operational UpdateAugust 13, 2024 | seekingalpha.comChimerix, Inc. (CMRX) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comChimerix Q2 2024 Earnings PreviewAugust 7, 2024 | marketbeat.comChimerix (CMRX) Scheduled to Post Earnings on TuesdayChimerix (NASDAQ:CMRX) will be releasing earnings before the market opens on Tuesday, August 13, Zacks reports.July 9, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Stock Crosses Below 200 Day Moving Average of $0.99Chimerix (NASDAQ:CMRX) Stock Price Crosses Below 200-Day Moving Average of $0.99July 5, 2024 | globenewswire.comChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 29, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Shares Pass Below 200-Day Moving Average of $0.99Chimerix (NASDAQ:CMRX) Stock Crosses Below 200 Day Moving Average of $0.99June 18, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Stock Price Passes Below Two Hundred Day Moving Average of $0.99Chimerix (NASDAQ:CMRX) Share Price Crosses Below Two Hundred Day Moving Average of $0.99June 9, 2024 | marketbeat.comVestal Point Capital LP Invests $1.35 Million in Chimerix, Inc. (NASDAQ:CMRX)Vestal Point Capital LP bought a new stake in Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,400,000 shares of the biopharmaceutical company's stock, valued at approximaJune 8, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Lifted to Hold at StockNews.comStockNews.com raised Chimerix from a "sell" rating to a "hold" rating in a research report on Saturday.June 3, 2024 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Short Interest Down 5.9% in MayChimerix, Inc. (NASDAQ:CMRX - Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,280,000 shares, a drop of 5.9% from the April 30th total of 1,360,000 shares. Based on an average trading volume of 338,000 shares, the short-interest ratio is currently 3.8 days. Approximately 1.6% of the company's shares are sold short.May 30, 2024 | globenewswire.comChimerix to Participate in Fireside Chat at Jefferies Global Healthcare ConferenceMay 29, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Rating Increased to Hold at StockNews.comStockNews.com upgraded shares of Chimerix from a "sell" rating to a "hold" rating in a research report on Wednesday.May 24, 2024 | barrons.comChimerix Inc.May 3, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Downgraded by StockNews.com to "Sell"StockNews.com cut Chimerix from a "hold" rating to a "sell" rating in a report on Friday.May 3, 2024 | markets.businessinsider.comBuy Rating Justified by Chimerix’s Upcoming Catalysts and Strong FinancialsMay 3, 2024 | marketbeat.comBrokers Offer Predictions for Chimerix, Inc.'s FY2028 Earnings (NASDAQ:CMRX)Chimerix, Inc. (NASDAQ:CMRX - Free Report) - Equities research analysts at Capital One Financial reduced their FY2028 earnings per share estimates for shares of Chimerix in a research report issued on Wednesday, May 1st. Capital One Financial analyst N. Quibria now anticipates that the biopharmacMay 2, 2024 | markets.businessinsider.comStrong Buy Rating for Chimerix on Robust Financials and Promising Drug PipelineMay 2, 2024 | finance.yahoo.comChimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comChimerix (NASDAQ:CMRX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPSChimerix (NASDAQ:CMRX - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.04). Chimerix had a negative net margin of 25,337.96% and a negative return on equity of 37.93%. During the same quarter in the previous year, the firm posted ($0.24) EPS.May 2, 2024 | markets.businessinsider.comChimerix’s Strong Financials and Promising ONC201 Developments Merit Buy RatingMay 2, 2024 | finance.yahoo.comChimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...May 2, 2024 | au.finance.yahoo.comQ1 2024 Chimerix Inc Earnings CallMay 1, 2024 | msn.comChimerix GAAP EPS of -$0.25May 1, 2024 | sfgate.comChimerix: Q1 Earnings SnapshotMay 1, 2024 | globenewswire.comChimerix Reports First Quarter 2024 Financial Results and Provides Operational UpdateApril 30, 2024 | markets.businessinsider.comWhat Wall Street expects from Chimerix's earningsApril 25, 2024 | marketbeat.comChimerix (CMRX) Set to Announce Quarterly Earnings on WednesdayChimerix (NASDAQ:CMRX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports.April 24, 2024 | globenewswire.comChimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024April 16, 2024 | globenewswire.comChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 15, 2024 | finance.yahoo.comWe Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Kamala’s Dirty Election Move… Revealed (Ad)According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. CMRX Media Mentions By Week CMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRX News Sentiment▼0.960.55▲Average Medical News Sentiment CMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRX Articles This Week▼31▲CMRX Articles Average Week Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fortress Biotech News Today Nature's Sunshine Products News Today Solid Biosciences News Today Kyverna Therapeutics News Today Monte Rosa Therapeutics News Today CorMedix News Today Inozyme Pharma News Today Foghorn Therapeutics News Today Aurora Cannabis News Today UroGen Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.